AI assistant
ANGIODYNAMICS INC — Director's Dealing 2019
Jul 19, 2019
32939_dirs_2019-07-19_d87299c9-7423-4b7f-80a6-1bd506ebd0e6.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ANGIODYNAMICS INC (ANGO)
CIK: 0001275187
Period of Report: 2019-07-17
Reporting Person: Greiner Michael (EVP and CFO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-07-17 | Common Stock | A | 7660 | — | Acquired | 28391 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-07-17 | Non-Qualified Stock Option (right to buy) | $21.54 | A | 25621 | Acquired | 2029-07-17 | Common Stock (25621) | Direct |
Footnotes
F1: This acquisition of 7,660 shares of common stock ("Common Stock") of AngioDynamics, Inc. represents 7,660 restricted stock units, each of which represents a contingent right to receive one share of Common Stock. These restricted stock units vest in four equal installments beginning on July 17, 2020, such that 25% of the restricted stock units will vest on each of July 17, 2020, 2021, 2022 and 2023.
F2: These stock options vest in four equal annual installments beginning on July 17, 2020, such that 25% of the options will vest on each of July 17, 2020, 2021, 2022 and 2023.